Skip to main content
EMVISION MEDICAL DEVICES LTD logo

EMVISION MEDICAL DEVICES LTD — Investor Relations & Filings

Ticker · EMV ISIN · AU0000028375 ASX Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2023-09-19 AGM Information
Country AU Australia
Listing ASX EMV

About EMVISION MEDICAL DEVICES LTD

https://emvision.com.au/

EMVision Medical Devices Ltd is a medical technology company focused on the development and commercialization of portable medical imaging devices. The company specializes in electromagnetic microwave imaging technology designed for the rapid diagnosis and monitoring of stroke and traumatic brain injury. Its primary product is a portable brain scanner intended for use at the point of care, including intensive care units, emergency departments, and ambulances. By utilizing non-ionizing radiation, the technology provides a safe, cost-effective, and mobile alternative to traditional neuroimaging modalities like CT and MRI. The device aims to facilitate earlier clinical intervention by enabling bedside assessment, potentially improving patient outcomes through faster detection of ischemic and hemorrhagic strokes.

Recent filings

Filing Released Lang Actions
Date of AGM & Closing Date For Director Nominations 1
AGM Information Classification · 95% confidence The document announces the date of the Annual General Meeting (AGM) and the closing date for director nominations. It references compliance with ASX Listing Rule 3.13.1 and states that details of the meeting and resolutions will be provided in a Notice of AGM and Explanatory Memorandum sent later. The document does not contain the AGM materials themselves, nor financial data or results. It is a notification about the AGM date and related procedural information, fitting the category of AGM Information (AGM-R). The document length is short and it is clearly an announcement rather than the full AGM materials.
2023-09-19 English
Employee Incentive Plan Issue 3 pages 181.5KB
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from EMVision Medical Devices Ltd regarding the issuance of unlisted Performance Rights under its Employee Incentive Plan. It details the terms and conditions of these Performance Rights, including vesting, exercise conditions, and compliance with ASX Listing Rules. There is no financial data, financial statements, or report content. The document is a corporate announcement about employee incentive share awards, which relates to share capital changes but is not a full capital restructuring or financing update. It is not a report, transcript, or regulatory filing of financial results. The best fitting category is Share Issue/Capital Change (SHA) because it announces the issuance of performance rights convertible into shares under an employee incentive plan.
2023-09-17 English
Notification regarding unquoted securities - EMV 7 pages 31.0KB
Share Issue/Capital Change Classification · 100% confidence The document is a notification regarding the issue of unquoted equity securities, specifically performance rights issued under a new employee incentive plan. It details the number of securities issued, the purpose, and compliance with ASX listing rules. There are no financial statements or comprehensive financial data, nor is this a report or presentation. It is an announcement about a capital change involving new securities issuance. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive notification of securities issuance.
2023-09-17 English
Application for quotation of securities - EMV 6 pages 28.3KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX, specifically detailing the issuance of new ordinary fully paid shares resulting from the exercise of options or conversion of convertible securities. It includes information about the number of securities, issue dates, and the nature of the securities (performance rights converted to shares). There is no financial performance data, earnings information, or management discussion. The document is an announcement related to capital changes, specifically the issuance and quotation of new shares due to option exercises. This fits the category of Share Issue/Capital Change (SHA). The document length is sufficient and contains detailed information about the securities issued, not just a brief announcement or a report publication notice.
2023-09-17 English
Cleansing Notice 1 page 131.2KB
Regulatory Filings Classification · 95% confidence The document is a short announcement from EMVision Medical Devices Limited regarding the issuance of fully paid ordinary shares following the exercise of unlisted Performance Rights under the Employee Incentive Plan. It references compliance with sections of the Corporations Act related to securities issuance and disclosure exemptions. The document does not contain financial statements, detailed financial data, or management discussion. It is primarily a regulatory notice about share issuance and compliance with disclosure laws. Given the short length (1632 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-09-17 English
Notification of cessation of securities - EMV 4 pages 24.0KB
Regulatory Filings Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the expiry of options (securities) for Emvision Medical Devices Ltd. It provides specific information about the securities that have ceased, the reason for cessation (expiry of options), and the updated issued capital following these changes. The document is a regulatory announcement about changes in the company's securities, specifically the cessation of certain options. It does not contain financial statements, management discussion, or detailed financial results. It is not an annual or interim report, nor a call transcript or earnings release. It is not a report publication announcement since it contains substantive information about securities cessation. This fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-09-10 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.